Introduction {#sec1}
============

Bacteria surround their cytoplasmic membrane with a large, semipermeable barrier, the peptidoglycan (PG) sacculus, which not only protects the cell from lysis from turgor but also helps to maintain cell shape. PG comprises repeating units of the *N*-acetylglucosamine-*N*-acetylmuramic acid (Glc*N*Ac---Mur*N*Ac) disaccharide that polymerizes into long glycan chains. Pentapeptides, usually comprising L-Ala---D-γ-Glu\[Gln\]---L-Lys---D-Ala---D-Ala, extend from the Mur*N*Ac moiety. In Gram-negative bacteria and some Gram-positive Firmicutes, the L-Lys at position 3 is replaced by *meso*-diaminopimelic acid (A~2~pm), which is amidated in *Bacillus subtilis* ([@bib45]). Peptides protruding from adjacent glycan chains are crosslinked by transpeptidases to form the net-like PG sacculus, which the cell has to enlarge in order to grow and to divide ([@bib38]). Newly inserted PG matures and is turned over by PG hydrolases, and the balance between synthesis and degradation of PG is key to normal cell division ([@bib46]). The importance of PG to the healthy physiology of a bacterium is highlighted by the fact that its biosynthesis is the target of some of our most successful antibiotics, β-lactams such as penicillin and glycopeptides such as vancomycin, resistance to which in pathogens is an urgent and currently unmet human health challenge.

In most species, the terminal D-alanine of the nascent pentapeptide stem is hydrolysed by DD-carboxypeptidases from the class C *p*enicillin *b*inding *p*rotein (PBP) family ([@bib30]). LD-carboxypeptidases subsequently hydrolyze the L-Lys\[A~2~pm\]---D-Ala bond to release the tripeptide. Though tripeptides are found in many bacteria, very few of the corresponding LD-carboxypeptidases have been identified. Membrane preparations of *B. subtilis* have shown strong LD-carboxypeptidase activity against cell-wall-derived tetrapeptides ([@bib4]), though the specific enzyme involved has not been isolated. The best characterized LD-carboxypeptidase is LD-carboxypeptidase A (LdcA), a cytoplasmic, penicillin-insensitive member of the S66 family of serine peptidases that is involved in PG recycling and is essential for cells entering the stationary phase ([@bib33; @bib43]). The cytoplasmic localization of LdcA precludes its involvement in the production of cell wall tripeptides. Other LD-carboxypeptidases either must be active within the periplasm of Gram-negative bacteria or are anchored to the exterior of the cell membrane in Gram-positives.

Several LD-carboxypeptidase genes have been identified recently, including *dacB* from *Lactococcus lactis* and *Streptococcus pneumoniae* ([@bib6; @bib15]), *csd6* from *Helicobacter pylori* ([@bib41]) and *pgp2* from *Campylobacter jejuni* ([@bib21]), though it should be noted that *csd6* and *pgp2* share no sequence similarity with *dacB*. The corresponding null mutants exhibited increased amounts of tetrapeptides in the cell wall and a concomitant decrease in tripeptide content ([@bib41; @bib21]). The *S. pneumoniae dacB* mutant also displayed severe morphological defects, developing into small, spherical cells or elongating into long, thick cells, as a result of division asymmetry produced by random septum localization ([@bib6]). Both the *H. pylori csd6* and the *C. jejuni pgp2* mutants have a morphological defect, displaying a straight shape instead of the normal helical morphology, indicating that *csd6* and *pgp2* also contribute to cell shape maintenance ([@bib21; @bib41]). In *C. jejuni* ([@bib20]) and *H. pylori* ([@bib40]), cell shape is also linked to pathogenicity, and PG fragments released by growing cells are important signaling molecules for immune recognition and modulation in animals ranging from insects to man ([@bib37]). Therefore, the PG plays an important role in bacterial shape maintenance, viability, virulence and immune signaling.

In this study, we have investigated the biochemical activity of *S. pneumoniae* and *B. subtilis* DacB against cell wall sacculi and synthetic tetrapeptides. Both proteins are shown to be active against cell-wall-derived tetrapeptides and synthetic tetrapeptides lacking the sugar moiety but are inactive against tetrapeptides terminating in L-alanine, confirming their classification as LD-carboxypeptidases. We therefore propose to rename these enzymes LD-carboxypeptidase B (LdcB). We present the crystal structures of both LdcB enzymes and the ortholog from *Bacillus anthracis*, all of which belong to the LAS (*l*ysostaphin, D-*A*la-D-Ala metallopeptidases, *s*onic hedgehog) family of zinc-dependent peptidases. The structure of *S. pneumoniae* LdcB with Mur*N*Ac---L-Ala---D-γ-Gln---L-Lys---(D-Asn) bound reveals the molecular basis of PG recognition and the key roles played in catalysis by active site elements. It is surprising that the active site is reminiscent, yet reversed, of that found in pancreatic carboxypeptidase A, suggesting that the enzymes have converged on a common catalytic mechanism.

Results {#sec2}
=======

Role for LdcB In Vivo {#sec2.1}
---------------------

The mature PG of *S. pneumoniae* and *B. subtilis* contains mostly tripeptides, indicating the presence of PG-active peptidases in these organisms ([@bib5; @bib11]). Both species contain DacA orthologs, DD-carboxypeptidases that cleave pentapeptides to tetrapeptides; however, the LD-carboxypeptidases that produce tripeptides from the tetrapeptides have remained elusive until recently. The PG of a *S. pneumoniae dacB* mutant contained mainly tetrapeptides, suggesting strongly that *Sp*DacB is an LD-carboxypeptidase (hereinafter renamed as *Sp*LdcB) ([@bib6]). Single mutants of the *dacA* and *dacB* orthologs in *B. subtilis*, *dacA*, and *yodJ* (hereinafter renamed as *ldcB*), had no obvious phenotype during vegetative growth, indicating that the trimming of peptides or the released D-Ala is not required for growth under laboratory conditions ([@bib5]). To test whether the released D-Ala becomes important under D-Ala limiting conditions, we constructed *dacA* and *ldcB* null mutants in a *B. subtilis* strain auxotrophic for D-Ala (an alanine racemase \[*alrA*\] null mutant) and assayed growth in the presence of D-Ala. The D-Ala-dependent strain, RD180, required at least 450 μM D-Ala for normal growth, and it grew more slowly at lower D-Ala concentrations ([Figure 1](#fig1){ref-type="fig"}). However, strains also bearing either the *dacA* (KS03) or the *ldcB* (KS02) alleles exhibited even more severe growth rate dependencies on D-Ala, with the *dacA* mutant the most severely affected. These data suggest strongly that LdcB is an LD-carboxypeptidase that releases D-Ala from the cell wall, which can be used to support growth under D-Ala-limiting conditions.

To test directly whether LdcB functions as an LD-carboxypeptidase, we generated *S. pneumoniae* and *B. subtilis ldcB* mutants and isolated their cell wall PG. Muropeptides were released with cellosyl and analyzed by HPLC ([Figures 2](#fig2){ref-type="fig"}A and 2B). The *ldcB* mutant strains lacked tripeptides and contained mainly tetrapeptides in their PGs, consistent with previous work indicating that LdcB is the main enzyme trimming cell wall tetrapeptides ([@bib6]). To obtain more direct evidence for an enzymatic activity, purified, recombinant LdcB enzymes from *S. pneumoniae* and *B. subtilis* (termed *Sp*LdcB and *Bs*LdcB) were incubated with PG isolated from the respective *ldcB* mutant strains before digesting with cellosyl and analyzing the resulting muropeptides by HPLC ([Figures 2](#fig2){ref-type="fig"}A and 2B). Both *Sp*LdcB and *Bs*LdcB almost quantitatively digested PG tetrapeptides with a carboxy-terminal D-Ala producing the tripeptides, proving their LD-carboxypeptidase activity. *Sp*LdcB was active in the presence of Zn^2+^ ions and inactive in the presence of EDTA, suggesting a metal-ion-dependent peptidase mechanism.

SpLdcB and BsLdcB Are Catalytically Active against Synthetic Cell Wall Tetrapeptides {#sec2.2}
------------------------------------------------------------------------------------

In addition to removing the terminal D-Ala from *S. pneumoniae* cell wall PG tetrapeptides ([Figure 2](#fig2){ref-type="fig"}A), *Sp*LdcB was also tested against synthetic tetrapeptides (L-Ala---D-Gln---L-Lys---D-Ala \[tetra-D\]) and its L-isomer, L-Ala---D-Gln---L-Lys---L-Ala \[tetra-L\]). Though these substrates lack the glycan component and differ further from the natural substrate by the replacement of D-γ-glutamine with D-glutamine, they have the potential to discriminate between LD- and LL-carboxypeptidase activities. *Sp*LdcB was active solely against the tetra-D ligand ([Figure 2](#fig2){ref-type="fig"}C), an activity that was dependent on the presence of zinc and abrogated totally in the presence of EDTA ([Figure 2](#fig2){ref-type="fig"}C).

Overall Structure of LdcB {#sec2.3}
-------------------------

The crystal structures of *Sp*LdcB and *Bacillus anthracis* LdcB (*Ba*LdcB) were solved by single wavelength anomalous dispersion (SAD); *Bs*LdcB was solved by molecular replacement. The LdcB enzymes are single domain proteins comprising two subdomains separated by a V-shaped cleft ([Figures 3](#fig3){ref-type="fig"}A--3C). The first subdomain comprises a four-stranded, antiparallel β sheet (β4--β7) that opposes the cleft, and the outside face of the β sheet is flanked by three α helices (α1, α4, and α6). The second subdomain comprises an N-terminal, three-stranded, antiparallel β sheet (β1--β3), somewhat discrete from the four helical bundle (α2, α3, α5, and α7) that makes up the rest of the subdomain. Though the *Ba*LdcB structure contains the same subdomain, it is less well structured in this region than *Bs*LdcB and *Sp*LdcB, and, as a consequence, the β1--β3 sheet is not formed. Neither subdomain is formed by a contiguous, linear part of the primary sequence; six loops (β3--α1, β4--α2, α3--β5, β6--α5, α5--β7, and α6--α7) connect the two subdomains.

The cleft between subdomains is 15--18 Å wide at the top and 15 Å deep and narrows down to the base where a Zn^2+^ ion, added to the enzyme during purification, is located ([Figures 3](#fig3){ref-type="fig"}A--3C), which is coordinated in a tetrahedral manner by three amino acids. In *Sp*LdcB, the liganding residues are His153, Asp160, and His207 ([Figure 3](#fig3){ref-type="fig"}D); the equivalents in *Bs*LdcB*/Ba*LdcB are His185/His160, Asp192/Asp167, and His244/His219 ([Figures 3](#fig3){ref-type="fig"}E and 3F). These zinc ligands are universally conserved in LdcB sequences, consistent with an important functional role in these enzymes. The active site of *Sp*LdcB contains unattributed residual electron density that occupies the position of the fourth ligand in the tetrahedral coordination sphere of the zinc ([Figure 3](#fig3){ref-type="fig"}D). To use the nomenclature common to proteases, the unattributed electron density extends as far as the S~1~′ subsite, the location ordinarily occupied by the scissile amino acid. The electron density in the S~1~′ subsite is of a size, shape, and location corresponding to that of alanine. The ligand is stabilized in this position by van der Waals' contacts between the alanyl methyl group and the phenolic side chains of Tyr191 and Tyr201 and by hydrogen bonds to the side chains of Glu204 and the main chain amide nitrogen of Tyr144. Despite the high resolution of the *Sp*LdcB diffraction data, it was not possible to discriminate between either alanyl stereoisomer, both of which are present in the crystallization conditions. We have modeled D-Ala because it is the enzymatic product of these enzymes. However, residual electron density adjacent to the zinc ion could not be modeled satisfactorily with any ligand arising from the enzymatic activity, the crystallization media, or purification media; consequently, the remaining electron density has been left unmodeled. Mass differences between native and denatured protein samples also failed to identify candidate molecules corresponding to the residual electron density. Residual electron density in the vicinity of the fourth zinc ligand in *Bs*LdcB was fulfilled by a phosphate anion, a component of the crystallization conditions ([Figure 3](#fig3){ref-type="fig"}E), which refined satisfactorily. The phosphate is located so as to mimic the tetrahedral transition state of amide bond hydrolysis. There is a further unmodeled electron density feature ([Figure 3](#fig3){ref-type="fig"}E), this time in the S~1~′ subsite, that we have not been able to identify unambiguously.

Comparison of LdcB Structures {#sec2.4}
-----------------------------

*Sp*LdcB, *Ba*LdcB, and *Bs*LdcB share pairwise sequence identities of ∼30%, and they superimpose on ∼155 common C~α~ atoms with a root-mean-square deviation (rmsd) of 1.5 Å--1.8 Å ([Figures 3](#fig3){ref-type="fig"}A--3C). The major differences between the LdcB structures are limited to the rather flexible and unconstrained N- and C-termini and the occasional longer loop in one structure in comparison to the other, as a direct consequence of sequence insertions. The active sites of *Sp*LdcB, *Ba*LdcB, and *Bs*LdcB are, to all extents and purposes, indistinguishable ([Figures 3](#fig3){ref-type="fig"}D--3F). A further *Ba*LdcB structure has been solved that contains no bound zinc ion, but there are negligible differences between it and its counterpart with zinc bound ([Figure S1](#app3){ref-type="sec"} available online). The active site of the LdcB enzymes is, therefore, sculpted in a robust fashion, competent for peptidolysis once the catalytic machinery is completed by the incorporation of zinc.

Structural Comparison with Other Peptidases {#sec2.5}
-------------------------------------------

Using *Sp*LdcB as a search model in DALI ([@bib24]), over 100 significantly similar structures were identified in the Protein Data Bank (PDB), including the structure of VanXY~G~, a dipeptidase/DD-carboxypeptidase (PDB ID [4f78](pdb:4f78){#intref0010} \[[@bib34]\]; DALI Z score = 17.0); an endolysin from the *Listeria* bacteriophage A500 (PDB ID [2vo9](pdb:2vo9){#intref0015} \[[@bib27]\]; Z = 9.5); VanX, a DD-dipeptidase (PDB ID [1r44](pdb:1r44){#intref0020} \[[@bib12]\]; Z = 6.6); and the N-terminal domain of sonic hedgehog, a protease involved in embryogenesis (PDB ID [2wg4](pdb:2wg4){#intref0025} \[[@bib8]\]; Z = 5.3). Equivalent results were obtained using the structures of *Ba*LdcB and *Bs*LdcB as queries in DALI. The matched structures are all members of the wider LAS superfamily of proteases ([@bib9]), which, although they share very little sequence identity, possess markedly similar active sites ([Figure 4](#fig4){ref-type="fig"}). By comparison with the VanXY~G~ structure ([@bib34]), the active site of the LdcB proteins is open and more solvent accessible. The open nature of the active site is a direct consequence of the absence of the β4-α5/bisubstrate selectivity loop in LdcB, which enables the recognition of PG, a molecule far greater in size than the dipeptides utilized by VanXY~G~ ([@bib34]).

As with other LAS superfamily members, LdcB contains the characteristic zinc binding motif ([Figure 4](#fig4){ref-type="fig"}), with a consensus sequence of H-X~(3--6)~-D-X~(not\ conserved)~-H. The fourth zinc ligand in the structures of other LAS family members tends to be a solute from the crystallization milieu or a water that is likely to act as the nucleophile in the reaction ([@bib12]). A second conserved motif in the LAS superfamily, H-X-H, of which the first histidine is the catalytic residue ([@bib9]), is missing from LdcB enzymes; the catalytic histidine is replaced spatially by glutamate (i.e., Glu204 in *Sp*LdcB).

SpLdcB Cocrystallized with a Reaction Product {#sec2.6}
---------------------------------------------

Despite attempting to crystallise LdcB enzymes with a range of synthetic ligands, one crystal structure was obtained, that of *Sp*LdcB in complex with Mur*N*Ac---L-Ala---D-γ-Gln---L-Lys---(D-Asn) ([Figure 5](#fig5){ref-type="fig"}A). This ligand is a close chemical analog of the true reaction product, as it contains half of the repeating unit of the glycan component of PG and comprises a tripeptide stem peptide that is branched at the L-lysine, the location of the crosslink position in natural PG ([Figures 5](#fig5){ref-type="fig"}F and 5G). There are two chemical differences between this synthetic mimic and the true reaction product. First, the ligand lacks Glc*N*Ac, the second sugar moiety of the glycan repeating unit in PG. Second, the terminal D-Asn group is covalently attached by a peptide bond between the main chain carbonyl of the terminal D-Asn and the side chain N~ζ~ of the penultimate lysine. In crosslinks between peptide stems, the side chain N~ζ~ of the penultimate lysine is linked by a peptide bond to the main chain carbonyl of a D-Ala. Hence, the L-Lys---(D-Asn) linkage is a faithful mimic of the natural L-Lys---(D-Ala), albeit the chemistry of the side chains of the terminal D-amino acids clearly differ.

There are six molecules of *Sp*LdcB in this crystallographic asymmetric unit, though none of the interfaces represent a stable multimeric form. Five of six protein chains could be built and refined satisfactorily; the electron density for the sixth copy could not be improved by any procedure to permit its reliable modeling, and its absence from the model contributes directly to the slightly inflated final *R*~work~ and *R*~free~ values ([Table 1](#tbl1){ref-type="table"}). The five built molecules are highly superimposable, with each other and with the apo *Sp*LdcB structure (rmsds between 0.5 Å and 1.1 Å; [Table 2](#tbl2){ref-type="table"}). In chains B, C, and E, the zinc is coordinated by a likely nucleophilic water to form tetrahedral coordination geometry. In chain D, the fourth zinc ligand is not evident, perhaps due to local disorder. Residual electron density was retained throughout refinement in only one of the five molecules, chain A, into which Mur*N*Ac---L-Ala---D-γ-Gln---L-Lys---(D-Asn) could be built and refined unambiguously ([Figure 5](#fig5){ref-type="fig"}A).

The structure of the ligand-bound form of *Sp*LdcB is entirely consistent with its LD-carboxypeptidase function. First, the Mur*N*Ac moiety is situated at the very top of the intersubdomain cavity and makes little contact with the protein. This part of the ligand has the highest B factors (a mean of 93 Å^3^, versus a mean of 83 Å^3^ for the intact ligand and a mean of 45 Å^3^ for all atoms modeled) and, thus, the weakest electron density. The Mur*N*Ac O1 and O4 atoms, which define the location of the flanking β1- to β4-linked Glc*N*Ac sugars in PG, project away from the protein surface so that the glycan chain would be accommodated by the protein without steric clashes. The *N*-acetyl group at C1 is stabilized against the side chain of Met202 by van der Waals' forces ([Figure 5](#fig5){ref-type="fig"}B).

The C~α~ and C~β~ atoms of L-alanine at position 1 of the peptide pack against the face of Tyr144, a conserved amino acid in many LdcB sequences, to discriminate against the D-stereoisomer in this subsite, S~3~. L-alanine is favored by contacts with Tyr144 and Met202, which discriminate against all L-amino acids bulkier than alanine ([Figure 5](#fig5){ref-type="fig"}B). The NH2 group of the D-γ-Gln of position 2 is located in subsite S~2~, 2.3 Å away from and in hydrogen bonding distance of Glu204 ([Figure 5](#fig5){ref-type="fig"}C), an invariant amino acid in LdcB sequences. Stereoselectivity at this position is maintained because L-γ-glutamine would clash with Tyr144. The γ-glutamine is selected for by specific interactions with the main chain carbonyl of Ala203 and the side chain of Glu204 while ensuring that the scissile peptide bond is in the catalytic position. These key aspects of molecular recognition could not occur with commonly occurring amino acids. Canonical glutamine can be accommodated at this position in the synthetic peptide, tetra-D, because the absence of contacts with one face of the peptide provides scope for the conformational changes needed to accommodate glutamine in the absence of the glycan strands of the natural substrate.

Position 3 of the peptide is occupied by L-lysine. D-lysine could not be accommodated at this position because of the presence nearby of Glu107. As expected of a reaction product complex, the lysine carboxylate is located adjacent to the active site zinc in subsite S~1~ ([Figure 5](#fig5){ref-type="fig"}D). One of the carboxylic oxygens completes the zinc tetrahedral geometry with His153/Asp160/His207, and the second oxygen forms a salt bridge with Arg120, which is either arginine or lysine in LdcB orthologs. The L-lysine carboxylate thus represents a posthydrolysis state, placed appropriately for the peptide bond of the substrate to be hydrolyzed by the water molecule that fulfils the fourth zinc ligand in the absence of substrate.

The side chain of the L-lysine twists back against the rest of the peptide and projects into the protein core to place the terminal D-Asn branch in subsite S~1~′, against the main chain atoms of Tyr144 and the side chains of Tyr191, Tyr201, and His207 ([Figure 5](#fig5){ref-type="fig"}E). The carbonyl of the L-Lys---(D-Asn) peptide bond is contacted by the side chain of Ser151. However, it should be noted that subsite S~1~′ would be occupied by the scissile D-alanine in the presence of the reaction substrate, and support for this hypothesis comes from the structure of VanXY~G~ solved in complex with a phosphinate transition state mimic ([Figure 6](#fig6){ref-type="fig"}A) (PDB ID [4muq](pdb:4muq){#intref0030}) ([@bib34]). The phosphinate moiety is a transition state mimic of peptide bond hydrolysis because the reaction proceeds via a tetrahedral intermediate that phosphinate mimics. VanXY~G~ superimposes on *Sp*LdcB with an rmsd of 1.6 Å on 144 matched C~α~s, and the alanyl carboxylate moiety of the phosphinate is situated in an analogous position to that of the L-Lys---(D-Asn) peptide linkage observed in *Sp*LdcB ([Figure 6](#fig6){ref-type="fig"}A). The phosphate atoms of the phosphinate transition state mimic superimpose almost identically with the phosphate anion modeled adjacent to the zinc ion in the structure of *Bs*LdcB ([Figure 3](#fig3){ref-type="fig"}D). Other than Ser151, a role in determining specificity for the terminal D-alanine can be invoked for Gln125, and both these amino acids are strictly conserved. The amide nitrogen of Ala146 also participates in stereoselectivity, but as this is a main chain atom, it is perhaps no surprise that sequence conservation is not maintained at this position.

However, crosslinks between peptide stems cannot be accommodated in the observed conformation because of the burial of the branched amino acid in subsite S~1~′ ([Figure 6](#fig6){ref-type="fig"}B). Mere rotation of the side chain torsion angles of the L-lysine would result in a more thermodynamically favored extended conformation for this side chain to result in it passing beyond Arg120, Leu128, and Tyr132 to project beyond the surface of the protein ([Figure 6](#fig6){ref-type="fig"}B; [Figure S2](#app3){ref-type="sec"}). In this conformation, crosslinked peptide stems attached to the terminal N~ζ~ would not be sterically occluded by the body of the protein, consistent with the observed cleavage of crosslinked peptides ([Figure 2](#fig2){ref-type="fig"}A). In some bacteria, the lysine is replaced with diaminopimelic acid, a carboxy derivative of lysine that is amidated in bacilli. While the amidocarboxy derivative could be stabilized in the observed conformation by a similar set of specific interactions, it would also sterically occlude crosslinked peptide stems. Diaminopimelic acid is thus likely to follow the same path predicted for lysine by forming a simple, extended conformation to project into solvent.

Several key structural changes occur on ligand binding in *Sp*LdcB ([Figure 7](#fig7){ref-type="fig"}; [Movie S1](#mmc2){ref-type="supplementary-material"}). First and foremost, substrates are occluded in the empty form of the enzyme by a loop between residues Gly163 and Glu171, which blocks access to the active site. Most of these residues (Asp167 to Glu171) move by 10--15 Å in the presence of ligand to open up the cleft by refolding into an additional turn at the N terminus of α-helix 4. The rearrangement of these residues is accompanied by further conformational changes in Trp206, the indole ring of which moves by up to 9 Å, which not only aids to open up the active site of the enzyme but also forces the side chain of Glu204 to rearrange to take up a position capable of interacting with the substrate. The importance of Glu204 and the zinc ion for catalysis is highlighted by the observation that tetra-D is a much poorer substrate for the E204A variant of *Sp*LdcB ([Figure 2](#fig2){ref-type="fig"}A) and by the absence of activity in the presence of EDTA ([Figures 2](#fig2){ref-type="fig"}A and 2C). The conformational changes seen on ligand binding to *Sp*LdcB contrasts with the absence of significant conformational changes described for VanXY~G~ in complex with phosphinate (PDB ID [4muq](pdb:4muq){#intref0035}) ([@bib34]). Like LdcB, VanXY~G~ maintains the H-X~(3--6)~-D-X~(not conserved)~-H motif, and as also observed in LdcB, the catalytic H-X-H motif is replaced by a glutamate. The resculpting of the N terminus of α-helix 4 in *Sp*LdcB to accommodate the tetrapeptide is not necessary in VanXY~G~, because this enzyme hydrolyzes a much smaller substrate, D-Ala-D-Ala dipeptide, which is accommodated by the enzyme without significant rearrangement.

Discussion {#sec3}
==========

The presence of tripeptides in the bacterial cell wall implies that LD-carboxypeptidase activity must be present in the extracellular milieu. In this study, we have shown that LdcB, from both *S. pneumoniae* and *B subtilis*, are active against tetrapeptides found within the bacterial cell wall and are specific for LD linkages, confirming the LD-carboxypeptidase classification with a role in cell wall maturation. The precise in vivo role for LdcB remains to be determined; one possibility is that the enzyme allows recycling of D-Ala from the cell wall to support further cell wall synthesis and, thus, growth. Alternatively, the cleavage of D-Ala from the cell wall might permit the differentiation between old and new cell walls, a potentially powerful way to ensure the correct localization of new cell wall synthesis. The correct localization of new PG synthesis is likely to be more important to bacteria that have polarized cell growth, such as *Streptococci*, in comparison to those that have dispersed growth along the length of a cylinder (e.g., *Bacilli*) or that utilize a division-only mechanism, such as *Staphylococci*. The cell morphological defect observed in the *S. pneumoniae ldcB* mutant, and the absence of defect in the *B. subtilis ldcB* mutant, could be consistent with this premise. Further studies should distinguish these possibilities.

We also present crystal structures of *Ba*LdcB, *Bs*LdcB, and *Sp*LdcB, the latter also in complex with a PG-fragment analog that has enabled the identification of amino acids key to molecular recognition of the substrate and a potential tunnel through which crosslinked PG peptides may pass during proteolysis. LdcB belongs to the LAS group of zinc metalloproteases; several members of this family are active against PG, albeit with different substrate specificities to LdcB, including the Gly-Gly endopeptidase lysostaphin ([@bib27]) and the DD-/LD-endopeptidase MepA ([@bib31]). LdcB is dissimilar to other groups of LD-carboxypeptidases, e.g., *Pseudomonas aeruginosa* LD-carboxypeptidase LdcA (PDB ID [1ZRS](pdb:1ZRS){#intref0040}) ([@bib28]) that degrades cell wall tetrapeptides in the cytoplasm. LdcA utilizes a Ser-His-Glu catalytic triad in catalysis and belongs to the S66 serine protease family of enzymes, a group with which LdcB shares no similarity ([@bib28]). Likewise, LdcB shares no sequence similarity with Csd6 and Pgp2, two recently discovered LD-carboxypeptidases that aid to maintain the helical shape of *H. pylori* ([@bib41]) and *C. jejuni* ([@bib21]). Csd6 and Pgp2 belong to an LD-transpeptidase family that utilizes a conserved Cys/His motif for catalysis ([@bib7]), and are, therefore, distinct from the metalloprotease LdcB. It is interesting that Csd6 can only hydrolyze D-Ala from monomeric stem peptides, whereas LdcB is active against both monomeric and crosslinked (tetra-tetra) stem peptides ([@bib42]), but the absence of structural similarity between these enzymes precludes useful comparison.

While LdcB shares no structural homology with previously studied LD-carboxypeptidases, DALI searches revealed a strong similarity to members of the LAS superfamily. Of the two consensus sequences that characterize the LAS family, LdcB lacks the second His-rich motif, which is replaced spatially by the invariant Glu204, which is oriented away from the zinc ion. Given the residual activity of the E204A mutant ([Figure 2](#fig2){ref-type="fig"}A), Glu204 probably plays an indirect role in catalysis. The zinc ion probably plays a more direct role in catalysis, a hypothesis that is supported by the absence of enzymatic activity in the presence of EDTA ([Figures 2](#fig2){ref-type="fig"}A and 2C). Further support for the role of the metal ion, and the indirect role for the glutamate, comes from studies of other zinc-dependent metalloproteases such as pancreatic carboxypeptidase A, which is of historical importance given its role in the demonstration of Koshland's induced fit hypothesis ([@bib14; @bib29]). Given the conformational changes seen on binding ligand ([Figure 7](#fig7){ref-type="fig"}; [Movie S1](#mmc2){ref-type="supplementary-material"}), LdcB appears to be another example of induced fit. Though the two enzymes are structurally distinct, the active sites of LdcB and pancreatic carboxypeptidase A are, in essence, mirror images of one another. Both contain a zinc ion coordinated by two histidines (His69 and His196 in carboxypeptidase A; His153 and His207 in *Sp*LdcB) and an acidic amino acid (Glu72 in carboxypeptidase A; Asp160 in *Sp*LdcB). *Sp*LdcB Arg120 and Glu204 straddle the nucleophilic water, but their positions relative to their counterparts in pancreatic carboxypeptidase A (Arg127 and Glu270) are reversed ([Figure 6](#fig6){ref-type="fig"}C). Consequently, the path of the substrate through the active site is also reversed. Given the retention of the metal coordination and key adjacent amino acids in LdcB, it is entirely plausible that the reaction mechanism of LdcB occurs in a similar fashion to that of pancreatic carboxypeptidase A, utilizing the metal ion to activate the nucleophilic water to attack the scissile peptide bond. The enzymes would thus appear to have converged on a common mechanism, despite sharing little overall sequence and structural homology. Confirmation of the catalytic mechanism utilized by this enzyme, and its precise role in vivo, is the focus of current research activities in our laboratories.

Experimental Procedures {#sec4}
=======================

Cloning {#sec4.1}
-------

*B. subtilis ldcB* and *S. pneumoniae ldcB* were amplified by PCR from *B. subtilis* 168 and *S. pneumoniae* R6 genomic DNA, respectively, to generate fragments with NdeI and XhoI restriction sites. Both fragments were digested with NdeI and XhoI and ligated with NdeI/XhoI-digested pET28a. *B. anthracis ldcB* was PCR amplified from *B. anthracis* str. *Ames ancestor* genomic DNA and cloned into p15TV-LIC ([@bib18]) that codes for a N-terminal His~6~ tag, followed by a tobacco etch virus (TEV) protease cleavage site. In all cases, the recombinant constructs were designed to remove membrane-anchoring amino acids to result in final clones encoding *Sp*LdcB amino acids 56--238; *Bs*LdcB, 61--273; and *Ba*LdcB, 55--243.

Strain Construction {#sec4.2}
-------------------

*S. pneumoniae* R6Δ*ldcB* was constructed by transforming strain R6 with a PCR product covering the *ldcB*-deletion region from strain IU3880 (D39 Δ*cps2A*′(*cps2BCDETFG*)*H*′Δ*dacB* \<\> P~c~-*kan-rpsL*) amplified with primers P136 and P137 ([@bib6]), followed by selection on tryptic soy broth blood agar plates containing 250 μg/ml kanamycin. All strains were grown in C + Y medium ([@bib25]), containing kanamycin if required. Competent bacteria were obtained as described elsewhere, with the addition of competence-stimulating peptide ([@bib44]).

*B. subtilis* strains were constructed by transformation of chromosomal DNA ([@bib3; @bib47]) from strains bearing null mutations for *dacA* (MC01, *trpC2* Δ*dacA cat*) or *yodJ* (MC05, *trpC2* Δ*yodJ neo*) into strain RD180 (*trpC2 ΔalrA zeo*), selecting for the appropriate resistance markers (chloramphenicol or kanamycin at 5 μg/ml) in the presence of 40 μg/ml D-alanine, yielding strains KS03 and KS02, respectively.

Growth Curves {#sec4.3}
-------------

*B. subtilis* strains RD180, KS02, and KS03 were grown overnight at 30°C in Luria broth (LB) supplemented with 40 μg/ml D-Ala. The overnight cultures were diluted 1:10 with LB supplemented with 40 μg/ml D-Ala and grown at 37°C for 2 hr. The cells were collected by centrifugation and resuspended in D-Ala-free media at 37°C. This suspension was used to inoculate media with various concentrations of D-Ala to an optical density 600 (OD~600~) of 0.05, and the subsequent growth of each culture at 37°C was monitored by determining the optical density at 600 nm every 20 min for 3 hr. The growth rate was determined during the exponential growth phase only.

Mutagenesis {#sec4.4}
-----------

A modified QuikChange protocol, incorporating "touchdown" ([@bib16]), was used for site-directed mutagenesis. The annealing temperature of the first 10 cycles was reduced by one degree per cycle, from 68°C to 58°C, before a further ten cycles were performed at a constant annealing temperature of 58°C. The extension temperature was maintained at 72°C for 11 min per cycle. Mutagenic primers (0.3 μl) were mixed with 50 ng of template DNA, 0.5 mM dinucleotide triphosphates, and 2.5 U of *Pfu* DNA polymerase in a total reaction volume of 20 μl. The template plasmid was digested using *Dpn*I.

Peptidoglycan Activity Assays {#sec4.5}
-----------------------------

Cell wall and PG from *S. pneumoniae* and *B. subtilis* strains were isolated by published procedures ([@bib11; @bib22]). To test for LD-carboxypeptidase activity, PG from *S. pneumoniae* R6Δ*ldcB* (1.6 mg/ml) or *B. subtilis* 168Δ*ldcB* (3.1 mg/ml) was incubated in a total volume of 160 μl of 20 mM sodium phosphate, pH 4.8, with 0.13 mg/ml *Sp*LdcB and 0.31 mg/ml *Bs*LdcB, respectively, for 16 hr at 37°C. If required, 0.6 mM Zn^2+^ or 10 mM EDTA was added, and control samples contained no added enzyme. The PG was digested with 25 μg/ml of the muramidase cellosyl (a kind gift of Hoechst AG) for 24 hr at 37°C. The samples were boiled for 10 min and centrifuged for 10 min at 15,000 × *g*. The muropeptides present in the supernatant were reduced with sodium borohydride and analyzed by high-pressure liquid chromatography (HPLC) ([@bib11; @bib22]). *S. pneumoniae* and *B. subtilis* muropeptide peaks were assigned based on their published elution profile and retention times ([@bib11; @bib5]). Fractions containing the reduced muropeptides Tetra and TetraTetra present in *B. subtilis* strain 168Δ*ldcB* were collected and analyzed by mass spectrometry ([@bib10]). We determined a neutral mass of 940.4353 atomic mass units (amu) for Tetra (theoretical: 940.4237 amu) and of 1862.8406 amu for TetraTetra (theoretical: 1862.8368 amu).

Thin-Layer Chromatography {#sec4.6}
-------------------------

Tetrapeptides Ala-D-Gln-L-Lys-D-Ala (Tetra-D; Activotec) or Ala-D-Gln-L-Lys-L-Ala (Tetra-L; Activotec) at 20 mM were incubated with 700 uM of zinc-loaded *Sp*LdcB or *Sp*LdcB-E153A for 2 hr at 37°C in a buffer of 10 mM HEPES/NaOH, pH 8.0, 100 mM NaCl in a reaction volume of 10 μl. One sample of *Sp*LdcB contained 50 mM EDTA. Ethanol (5 μl) was added to the reactions before spotting on to silica gel thin-layer chromatography (TLC) aluminum foils (Sigma). The TLCs were developed in a running buffer of butan-1-ol, acetic acid, water in a 3:1:1 ratio for 40 min before staining with 0.1% ninhydrin solution in ethanol (Sigma). The TLC foils were dried and warmed with a domestic hairdryer for visualizing the results.

Protein Overexpression and Purification {#sec4.7}
---------------------------------------

*Bs*LdcB and *Sp*LdcB were prepared in the same way. The proteins were overexpressed in the methionine auxotrophic B834(DE3) strain of *E. coli* by growth in LB media (or in minimal medium supplemented with selenomethionine for selenomethionine-labeled protein) at 37°C up to an OD~600~ of 0.4 before induction with 1 mM IPTG for 18 hr at 16°C. Cells were harvested by centrifugation at 3000 *g* for 25 min at 4°C and the pellet was resuspended in 40 ml buffer A (50 mM HEPES.NaOH, pH 8.0, 300 mM NaCl, 20 mM imidazole) per liter of culture and lysed on ice for 3 min with a Sonopuls HD2070 (Bandelin) sonicator. The cell lysate was clarified at 33000 *g* for 20 min and the supernatant loaded onto a 5 ml Ni^+^-NTA column (GE Healthcare) pre-equilibrated with buffer A. The column was washed with buffer A before elution of bound proteins with buffer B (50 mM HEPES/NaOH, pH 8.0, 300 mM NaCl, 500 mM imidazole). The fractions containing LdcB were pooled and the N-terminal hexahistidine tag was removed by digestion with thrombin (Sigma-Aldrich) at 20°C for 16 hr at a ratio of 1 unit of enzyme per mg of LdcB. LdcB was concentrated to a volume of 1 ml before loading onto a Superdex S75 HiLoad 16/60 (GE Healthcare) gel filtration column pre-equilibrated in buffer C (10 mM HEPES/NaOH, pH 8.0, 100 mM NaCl).

For *Ba*LdcB, freshly transformed *E. coli* BL21-CodonPlus (DE3)-RIPL cells were grown in 0.5 l of LB medium containing 100 μg/ml ampicillin. Cultures were grown at 37°C to an OD~600~ of 0.8 and induced for 16 hr at 16°C with 1 mM IPTG, and the cells were harvested by centrifugation and resuspended in 20 ml of buffer A (50 mM HEPES, pH 7.5, 300 mM NaCl, 10% \[v/v\] glycerol) supplemented with 10% (v/v) BugBuster 10× Protein Extraction Reagent (Novagen), 25 U Benzonase (Sigma-Aldrich), and 5 mM imidazole. The mixture was stirred for 10 min at room temperature and centrifuged at 20,000 × *g* for 45 min, and the supernatant was applied to a 1 ml HisTrap Fast Flow column (GE Healthcare) equilibrated with buffer A containing 40 mM imidazole. The protein was eluted with buffer A with a gradient of 40--500 mM imidazole over 20 ml. Fractions containing the recombinant His-tagged proteins were identified by SDS-PAGE; pooled; dialyzed overnight against 3 l of 50 mM HEPES, pH 7.5, 300 mM NaCl, 5% (v/v) glycerol, 1 mM TCEP; and stored at −80°C. The His~6~-tag was cleaved by TEV protease in 500 mM NaCl, 50 mM Tris-HCl, pH 7.5, 1 mM TCEP, 1 mM EDTA, 20% glycerol.

Crystallization {#sec4.8}
---------------

*Bs*LdcB and *Sp*LdcB were concentrated to 15 mg/ml, and two molar equivalents of zinc chloride were added. Crystallization conditions for *Bs*LdcB and *Sp*LdcB were obtained by sitting drop vapor diffusion at 20°C. The best *Sp*LdcB crystals were obtained from a 0.1 M mixture of amino acids (glycine, L-glutamate, and racemates of alanine, serine, and lysine), 0.1 M Morpheus buffer system 2, pH 7.5, and 37.5% 2-Methyl-2,4-pentanediol (MPD)/polyethylene glycol (PEG) 1000/PEG 3350 ([@bib23]). A single *Bs*LdcB crystal grew from 0.1 M phosphate/citrate buffer, pH 4.2, 40% PEG 300 over a period of ∼2 months. Crystals of *Sp*LdcB with bound Mur*N*Ac---L-Ala---D-γ-Gln---L-Lys---(D-Asn) (InvivoGen) were obtained by incubating the protein with the ligand at 2 mM final concentration for 30 min at room temperature prior to crystallization against a mother liquor of 0.1 M ammonium chloride, 0.1 M HEPES/NaOH, pH 8.0, and 20% PEG 6000. Crystals of *Ba*LdcB (zinc free) were grown at 23°C using hanging-drop vapor diffusion by mixing 20 mg/ml protein with reservoir solution containing 0.3 M sodium chloride, 0.1 M HEPES, pH 7.5. As soaking of zinc chloride into *Ba*LdcB apo-protein crystals did not provide sufficient occupancy of zinc into the active site, crystals of *Ba*LdcB (zinc bound) were grown at 23°C by hanging-drop vapor diffusion by mixing 20 mg/ml protein and 5 mM zinc chloride prior to crystallization with 0.2 M ammonium acetate, 0.1 M sodium acetate, and 30% PEG 4000.

Data Collection and Processing {#sec4.9}
------------------------------

All crystals were cryoprotected with paratone-N before flash cooling in liquid nitrogen prior to data collection at 100 K. Diffraction data for *Bs*LdcB and *Sp*LdcB were on beamline IO2 of the Diamond Light Source. For selenomethionine-labeled *Sp*LdcB, diffraction data were collected at a wavelength of 0.98 Å to permit phasing by selenomethionine-SAD (Se-SAD). Diffraction data were integrated with XDS ([@bib26]) and reduced with SCALA ([@bib19]). For *Ba*LdcB, diffraction data were collected at on beamlines 21-ID-G at Life Sciences Collaborative Access Team, Advanced Photon Source, at 0.97856 Å (selenomethionine peak; zinc free) and 1.27696 Å (Zn^2+^ peak; zinc bound). The *Ba*LdcB diffraction data were integrated and reduced with HKL-3000 ([@bib35]).

Structure Solution {#sec4.10}
------------------

The structure of *Sp*LdcB was solved using SHELX ([@bib39]) as implemented in the HKL2MAP interface ([@bib36]). An initial model was built by PHENIX.AUTOSOLVE ([@bib1]). The completed *Sp*LdcB structure was used as the molecular replacement search model in PHASER ([@bib32]) to solve *Bs*LdcB and the *Sp*LdcB-ligand complex. The *Ba*LdcB Zn^2+^-bound structure was solved by SAD phasing using PHENIX.solve ([@bib1]), which identified the positions of the two bound Zn^2+^ ions. The occupancies of the zinc atoms were refined during model refinement. The *Ba*LdcB Zn^2+^-free structure was solved by molecular replacement using the D,D-peptidase domain of the apo structure of VanXY~G~ (PDB ID [4f78](pdb:4f78){#intref0045}) ([@bib34]).

For all structures, manual building cycles in COOT ([@bib17]) were interspersed with restrained refinement in PHENIX.REFINE ([@bib2]). B factors were refined isotropically for all structures apart from *Bs*LdcB, which was refined anisotropically. Noncrystallographic symmetry refinement was not used. Average B factor and geometric parameters were calculated using PHENIX and verified with PHENIX.refine and the Research Collaboratory for Structural Bioinformatics PDB Validation server. Data collection and final model refinement statistics for all structures can be found in [Table 1](#tbl1){ref-type="table"}. The graphics programs UCSF Chimera and PyMOL were used to generate all molecular figures presented.

Accession Numbers {#app1}
=================

The PDB accession numbers for *Sp*LdCB, *Bs*LdcB, *Sp*LdcB with bound ligand, apo *Ba*LdcB, and *Ba*LdcB with bound zinc reported in this paper are [4OX5](pdb:4OX5){#intref0050}, [4OX3](pdb:4OX3){#intref0055}, [4OXD](pdb:4OXD){#intref0060}, [4JID](pdb:4JID){#intref0065}, and [4MPH](pdb:4MPH){#intref0070}, respectively.

Supplemental Information {#app3}
========================

Document S1. Figures S1--S7Movie S1. Conformational Changes in SpLdcB on Ligand Binding, Related to Figure 7Morph interpolation (UCSF Chimera) of the structural changes that occur upon ligand binding in *Sp*LdcB. α-helices are shown in red, β-strands are in yellow, and loops between secondary structure elements are colored silver. The bound zinc ion is shown as a grey sphere. Key residues that move on ligand binding are shown in stick representation, and the movie was rendered in PyMOL.Document S2. Article plus Supplemental Information
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![Effect of *dacA* and *ldcB* Alleles in a D-alanine Auxotroph\
(A**--**C) The growth of strains (A) RD180 (Δ*alrA*), (B) KS02 (Δ*ldcB*Δ*alrA*), and (C) KS03 (Δ*dacA*Δ*alrA*) incubated at 37°C in LB medium supplemented with different concentrations of D-alanine was determined by monitoring the culture at OD~600~ and plotting it against time of incubation.\
(D) The calculated growth rate of each strain at three different concentrations of exogenous D-alanine. The values shown represent the average of three independent experiments. The dashed line shows the growth rate of wild-type *B. subtilis* strain 168CA under the same conditions. The error bars represent the SD of growth rate means at a confidence level of 95%.](gr1){#fig1}

![Activity of *Sp*LdcB and *Bs*LdcB against Peptidoglycan and Peptides\
(A) HPLC chromatograms of muropeptides from *S. pneumoniae* strains, obtained after incubating PG with or without *Sp*LdcB or *Sp*LdcB(E204A) in the presence of Zn^2+^ or EDTA, followed by digestion with cellosyl and reduction with sodium borohydride. The muropeptides are: Tri, Glc*N*Ac---Mur*N*Ac(r)---L-Ala---D-γ-Gln---L-Lys; Tetra, Glc*N*Ac---Mur*N*Ac(r)---L-Ala---D-γ-Gln---L-Lys-D-Ala; TetraTri, Glc*N*Ac---Mur*N*Ac---L-Ala---D-γ-Gln---L-Lys---D-Ala---L-Lys---D-γ-Gln---L-Ala---Mur*N*Ac(r)---Glc*N*Ac; TetraTetra, Glc*N*Ac---Mur*N*Ac---L-Ala---D-γ-Gln---L-Lys---(D-Ala)---D-Ala---L-Lys---D-γ-Gln---L-Ala---Mur*N*Ac(r)---Glc*N*Ac; deAc, deacetylation at Glc*N*Ac; SA, L-Ser---L-Ala branch (at L-Lys). Glc*N*Ac, *N*-acetylglusosamine; Mur*N*Ac(r), *N*-acetylmuramitol.\
(B) HPLC chromatograms of muropeptides from *B. subtilis* strains, obtained after incubating PG with or without *Bs*LdcB, followed by digestion with cellosyl and reduction with sodium borohydride. Muropeptides: Tri, Glc*N*Ac---Mur*N*Ac(r)---L-Ala---D-γ-Glu---*meso*-Dap(NH~2~); Tetra, Glc*N*Ac---Mur*N*Ac(r)---L-Ala---D-γ-Glu---*meso*-Dap(NH~2~)---D-Ala; TetraTri, Glc*N*Ac---Mur*N*Ac---L-Ala---D-γ-Glu---*meso*-Dap(NH~2~)---D-Ala-*meso*-Dap(NH~2~)--- D-γ-Glu---L-Ala---Mur*N*Ac(r)---Glc*N*Ac; TetraTetra, Glc*N*Ac---Mur*N*Ac---L-Ala---D-γ-Glu---*meso*-Dap(NH~2~)---(D-Ala)---D-Ala---*meso*-Dap(NH~2~)--- D-γ-Glu---L-Ala---Mur*N*Ac(r)---Glc*N*Ac; *meso*-Dap(NH~2~), *meso*-diaminopimelic acid (amidated).\
(C) TLC of *Sp*LdcB incubated with various substrates.](gr2){#fig2}

![Structure of LdcB\
(A--C) Cartoon representations of (A) *Sp*LdcB, (B) *Bs*LdcB, and (**C**) *Ba*LdcB; α helices (red) and β strands (yellow) are numbered. The loops between secondary structure elements are colored silver. The bound zinc ion is shown as a gray sphere.\
(D--F) The active sites of (D) *Sp*LdcB, (E) *Bs*LdcB, and (F) *Ba*LdcB. A zinc ion is coordinated in a tetrahedral manner in the structures by two invariant histidines and a well-conserved aspartate. Residual electron density in *Sp*LdcB, shown in (D), corresponds to D-alanine in the S~1~′ subsite, and an unknown compound in S~1~, adjacent to the zinc ion. Electron density corresponding to a phosphate ion, a component of the crystallization medium, in the S~1~ subsite of *Bs*LdcB shown in (E) is a mimic of the tetrahedral transition state. A second feature in the S~1~′ subsite is unmodeled. The residual difference density features are shown contoured at a level of 3σ and hydrogen bonds are drawn as dashed black lines.](gr3){#fig3}

![A Comparison of the Active Sites of LdcB and Other LAS Family Members\
LdcB shares an active site closely superimposable on those of other LAS family enzymes. The zinc is coordinated by a H-X~(3--6)~-D-X~(not\ conserved)~-H motif. A glutamate that plays a key role in catalysis is also shown; note that, in D-Ala-D-Ala carboxypeptidase from *Streptomyces albus*, the equivalent amino acid is histidine, the first amino acid in the H-X-H motif common to most LAS carboxypeptidases. The structures shown, distinguished by the coloring of carbon atoms, are *Sp*LdcB (white), *Bs*LdcB (green), *Ba*LdcB (orange), *Enterococcus faecalis* D,D-dipeptidase/D,D-carboxypeptidase VanXY~G~ (yellow; PDB ID [4f78](pdb:4f78){#intref0080}), *Enterococcus faecium* aminodipeptidase VanX (blue; PDB ID [1r44](pdb:1r44){#intref0085}) and *S. albus* D-Ala-D-Ala carboxypeptidase (pink; PDB ID [1lbu](pdb:1lbu){#intref0090}).](gr4){#fig4}

![*Sp*LdcB with Bound Mur*N*Ac---L-Ala---D-γ-Gln---L-Lys---(D-Asn)\
(A) Cartoon representation of *Sp*LdcB, drawn using the same color scheme as in [Figure 3](#fig3){ref-type="fig"}. The Mur*N*Ac---Ala---D-γ-Gln---L-Lys---(D-Asn) is drawn as a ball-and-stick model with Refmac-weighted 2F~obs~-F~calc~ electron density displayed at a contour level of 1 σ.\
(B--E) The interactions made between the ligand and the protein at each subsite are shown successive panels: (B) S~3~; (C) S~2~; (D) S~1~, and (E) S~1~′. Key van der Waals' interactions are shown as a transparent silver line.\
(F) A schematic of the interactions of *Sp*LdcB with the bound peptidoglycan mimic. Hydrogen-bond interactions are shown with a black dotted line, and van der Waals' forces are shown with a green arc.\
(G) A schematic of the tetrapeptide substrate of *Sp*LdcB, drawn in the same manner as the peptidoglycan mimic in (F). The scissile bond is highlighted by an arrow. Crosslinks to other stem peptides would take place via the lysine's terminal amino group on the left.](gr5){#fig5}

![A Comparison of the Ligand-Bound Active Sites Carboxypeptidases\
(A) The active site of *Sp*LdcB (white) with bound Mur*N*Ac---L-Ala-D-γ-Gln---L-Lys---(D-Asn) (turquoise carbons) is compared to that of VanXYg (blue) containing a phosphinate transition state analog (pink carbons) of D-Ala---D-Ala (PDB ID [4muq](pdb:4muq){#intref0095}). The phosphinate in VanXYg coordinates the active site zinc in a similar manner to that of the lysyl carboxylate in the Mur*N*Ac---L-Ala-D-γ-Gln---L-Lys---(D-Asn) bound to *Sp*LdcB. The D-alanyl moiety of the phosphinate ligand in VanXYg, which occupies subsite S~1~′, is matched by the D-alanine (green carbons) in *Sp*LdcB (white) and the D-Asn of the Mur*N*Ac---L-Ala-D-γ-Gln---L-Lys---(D-Asn) ligand. The zinc ions are shown as gray spheres.\
(B) The proposed positions of the two posthydrolysis ligands (orange carbons) in the active site of *Sp*LdcB (white). The D-alanine from the *Sp*LdcB structure occupies the S~1~′ site of the protein, while the lysine side chain has been rotated and modeled in an extended conformation. The altered conformation of the lysine presents the N~ζ~ to the surface of the protein, in an ideal position to accommodate peptide crosslinks. The zinc ions are shown as gray spheres.\
(C) The active sites of *Sp*LdcB and pancreatic carboxypeptidase A (PDB ID [1hdu](pdb:1hdu){#intref0100} \[[@bib13]\]) are compared. In each structure, the Zn^2+^ ion is coordinated by two histidines (His69 and His196 in carboxypeptidase A; His153 and His207 in *Sp*LdcB) and an acidic amino acid (Glu72 in carboxypeptidase A; Asp160 in *Sp*LdcB). The reversed locations of Arg127 and Glu270 in carboxypeptidase A relative to Arg120 and Glu204 in *Sp*LdcB is matched by a reversal of the path of the respective substrates through the active sites and the likely retention of a common catalytic mechanism.](gr6){#fig6}

![Conformational Changes in *Sp*LdcB on Ligand Binding\
(A and B) Cartoon representations of (A) apo *Sp*LdcB and (B) *Sp*LdcB with bound Mur*N*Ac-Ala-D-γ-Gln-Lys-(D-Asn) using the same color scheme as in [Figure 3](#fig3){ref-type="fig"}. Key residues that move on ligand binding are shown in stick representation.](gr7){#fig7}

###### 

Summary of X-Ray Data Collection and Refinement Statistics

  Parameters                                             *Sp*LdcB                        *Bs*LdcB                        *Sp*LdcB with Ligand            *Ba*LdcB                        *Ba*LdcB with Zinc
  ------------------------------------------------------ ------------------------------- ------------------------------- ------------------------------- ------------------------------- -------------------------------
  PDB ID                                                 [4OX5](pdb:4OX5){#intref0105}   [4OX3](pdb:4OX3){#intref0110}   [4OXD](pdb:4OXD){#intref0115}   [4JID](pdb:4JID){#intref0120}   [4MPH](pdb:4MPH){#intref0125}
                                                                                                                                                                                         
  **Data collection**                                                                                                                                                                    
                                                                                                                                                                                         
  Space group                                            *I*222                          *P*2~1~2~1~2~1~                 *C*2                            *I*222                          *I*222
                                                                                                                                                                                         
  **Unit Cell Dimensions**                                                                                                                                                               
                                                                                                                                                                                         
   *a, b, c* (Å)                                         48.8, 60.4, 138.2               42.7, 53.7, 102.4               346.0, 42.5, 79.3               76.6, 113.0, 124.6              76.8, 112.3, 125.7
   α, β, γ (°)                                           90, 90, 90                      90, 90, 90                      90, 93.1, 90                    90, 90, 90                      90, 90, 90
  Wavelength (Å)                                         0.98                            0.97                            0.92                            0.97856                         1.27696
  Resolution (Å)                                         20.0--1.80 (1.84--1.80)         47.6--1.70 (1.73--1.70)         47.8--2.80 (2.95--2.80)         29.7--2.30 (2.36--2.30)         28.3--2.03 (2.06--2.03)
  Multiplicity                                           24.3 (14.2)                     3.2 (1.7)                       3.4 (3.4)                       4.2 (3.6)                       11.8 (9.9)
  R~merge~[a](#tblfn1){ref-type="table-fn"}              0.077 (0.108)                   0.072 (0.235)                   0.134 (0.635)                   0.093 (0.542)                   0.101 (0.511)
  I/σI                                                   34.4 (2.4)                      11.9 (2.4)                      7.8 (1.9)                       13.5 (2.4)                      32.1 (4.2)
  Completeness (%)                                       98.6 (86.9)                     95.7 (89.3)                     98.3 (98.3)                     98.3 (94.3)                     99.8 (96.9)
                                                                                                                                                                                         
  **Refinement**                                                                                                                                                                         
                                                                                                                                                                                         
  Resolution (Å)                                         20.0--1.80                      47.6--2.0                       47.8--2.80                      29.7--2.3                       28.3--2.03
  No. of reflections                                     25,656 (1,157)                  35,526 (1,057)                  47,327 (1,979)                  22,730 (1,226)                  67,494 (3,374)
  *R*~work~/*R*~free~[b](#tblfn2){ref-type="table-fn"}   0.191/0.253                     0.176/0.247                     0.273/0.335                     0.194/0.259                     0.151/0.189
                                                                                                                                                                                         
  **No. of Atoms**                                                                                                                                                                       
                                                                                                                                                                                         
   Protein                                               1,476                           1,753                           7,014                           3,040                           2,970
   No. of proteins/AU                                    1                               1                               6                               2                               2
   Ion/ligand                                            3/22                            1/5                             21/51                           -/4                             2/12
   Water                                                 197                             230                             111                             424                             466
                                                                                                                                                                                         
  **B Factors (Å^2^)**                                                                                                                                                                   
                                                                                                                                                                                         
   Protein                                               41.8                            16.0                            44.3                            45.3                            35.8
   Ion/ligand                                            36.9/50.7                       10.7/23.8                       38.7/69.7                       −/49.8                          17.9/60.0
   Water                                                 48.2                            31.6                            28.7                            43.6                            46.2
                                                                                                                                                                                         
  **Rmsd**                                                                                                                                                                               
                                                                                                                                                                                         
   Bond lengths (Å)                                      0.018                           0.015                           0.005                           0.013                           0.0012
   Bond angles (°)                                       1.96                            1.76                            0.84                            1.36                            0.991
                                                                                                                                                                                         
  **Ramachandran**                                                                                                                                                                       
                                                                                                                                                                                         
   Favored (%)                                           96.1                            96.7                            95.8                            97.6                            98.0
   Allowed (%)                                           100                             100                             99.6                            99.7                            100

Highest resolution shell shown in parentheses. AU, asymmetric units.

*R*~merge~ = Σ~h~Σ~i~\|*I*~i~(*h*) − 〈*I*(h)〉/Σ~h~Σ~i~I~i~(*h*), where *I*~i~(*h*) and 〈*I*(*h*)〉 are the *i*th and mean measurement of the intensity of reflection *h*.

*R*~work~*/R*~free~ = Σ\|F~p~^obs^ − F~p~^calc^\|/ΣF~p~^obs^, where F~p~^obs^ and F~p~^calc^ are the observed and calculated structure factor amplitudes, respectively.

###### 

Rmsd Values between Ligand-Bound *Sp*LdcB Chains (4OXD) and apo *Sp*LdcB (4OX5)

  4OX5 and 4OXD Chain   4OX5   4OXD Chain A   4OXD Chain B   4OXD Chain C   4OXD Chain D   4OXD Chain E
  --------------------- ------ -------------- -------------- -------------- -------------- --------------
  4OX5                  --     0.73           0.57           0.66           0.69           0.80
  4OXD chain A          0.73   --             0.63           0.64           0.76           1.03
  4OXD chain B          0.57   0.63           --             0.56           0.65           0.86
  4OXD chain C          0.66   0.64           0.56           --             0.56           0.64
  4OXD chain D          0.69   0.76           0.65           0.56           --             0.61
  4OXD chain E          0.80   1.03           0.86           0.64           0.61           --
